EPIDERM Triple action skin Cream / Lotion

Jesse O'Neil


Shalina Laboratories Pvt. Ltd.

COMPOSITION

  • Epiderm Cream (Each gram contains):

    • Betamethasone Dipropionate USP: 0.643 mg

    • Gentamicin Sulphate BP equivalent to Gentamicin base: 1 mg

    • Tolnaftate USP: 10 mg

    • Iodochlorhydroxyquinoline: 10 mg

    • Chlorocresol BP (Preservative): 1 mg

    • Excipients: Cetomacragol-1000 BP, Cetostearyl alcohol BP, White soft Paraffin BP, Purified water BP, Propylene Glycol BP, and Disodium Hydrogen Phosphate dihydrate BP.

  • Epiderm Lotion (Each ml contains):

    • Betamethasone Dipropionate USP: 0.643 mg

    • Gentamicin Sulphate BP equivalent to Gentamicin base: 1 mg

    • Tolnaftate USP: 10 mg

    • Iodochlorhydroxyquinoline: 10 mg

    • Chlorocresol BP (Preservative): 1 mg in a suitable base q.s.

    • Excipients: Cetomacragol-1000 BP, Cetostearyl alcohol BP, White soft Paraffin BP, Purified water BP, Paraffin liquid heavy BP, Propylene Glycol BP, and Disodium Hydrogen Phosphate dihydrate BP.

THERAPEUTIC INDICATIONS

Epiderm Cream / Lotion is indicated for the treatment of the following:

DOSAGE & DIRECTIONS FOR USE

Apply 2-3 times of Epiderm Cream / Lotion a day to the affected area or as directed by physician.

CONTRAINDICATIONS

  • Epiderm Cream / Lotion is contraindicated in patients who are hypersensitive to any of the components of the drug.

  • It is also contraindicated in the treatment of herpes simplex, vaccinia, or varicella.

ADVERSE REACTIONS

  • Epiderm Cream / Lotion is generally safe. Prolonged, continuous treatment may cause atrophy skin changes leading to: thinning, loss of elasticity, dilatation of superficial blood vessels, telangiectasiae, and ecchymoses.

  • Systemic absorption of corticosteroid can cause hypothalamic-pituitary-adrenal axis suppression, manifestation of Cushing's syndrome, hyperglycaemia, and glucosuria.

UNDESIRABLE EFFECTS

Epiderm Cream / Lotion is generally well tolerated. Some of the rarely reported side effects are:

  • Burning sensation, itching, irritation, dryness

  • Folliculitis, acneform eruptions, hypopigmentation

  • Maceration of the skin, secondary infection, skin atrophy, etc.

WARNINGS & PRECAUTIONS FOR USE IN SPECIAL POPULATIONS

  • Paediatric Use: HPA axis suppression, Cushing's syndrome, and intracranial hypertension have been reported in paediatric patients receiving topical corticosteroids.

  • Usage in Pregnancy & Lactation: Epiderm Cream / Lotion is not safe in pregnancy. Physicians should be consulted before initiating therapy with Epiderm Cream / Lotion for nursing mothers.

SYMPTOMS OF OVERDOSAGE & ITS TREATMENT

  • Excessive prolonged use of topical corticosteroids can suppress pituitary-adrenal functions resulting in secondary adrenal insufficiency, which is usually reversible.

  • In such cases, appropriate symptomatic treatment is indicated. If HPA axis suppression is noted, an attempt should be made to withdraw the drug, reduce the frequency of application, or substitute a less potent steroid.

PHARMACOLOGICAL CATEGORY & ACTION

  • Category: Epiderm Cream / Lotion is a combination of anti-fungal, anti-bacterial, & anti-inflammatory drugs, which provide synergistic action in the treatment of mixed bacterial & fungal infections.

  • Corticosteroids: Thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortin. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes.

  • Gentamicin: An aminoglycoside that binds to 30S and 50S ribosomal subunits of susceptible bacteria, disrupting protein synthesis, thus rendering the bacterial cell membrane defective.

  • Tolnaftate: An antifungal which inhibits growth of dermatophytes.

  • Iodochlorhydroxyquinoline: Has antibacterial and antifungal activity.

PHARMACOKINETICS

  • Absorption: Percutaneous absorption.

  • Elimination: Via urine.

DRUG INTERACTIONS

  • No interactions have been reported on local application with Epiderm Cream / Lotion. Avoid using other topical medications.

STORAGE CONDITION & HANDLING

  • Shake well before use.

  • For External Use Only. Do not swallow.

  • Do not store above 30°C. Protect from sunlight.

  • Keep out of reach of children.

PRESENTATION & REGULATORY DETAILS

  • Epiderm Cream: Pack of 15g & 30g — NAFDAC Reg. No.: A4-4676

  • Epiderm Lotion: Pack of 30ml — NAFDAC Reg. No.: A4-6173

  • Publication Date: 15/6/23

  • MK 3 : Shalina

Manufactured by / Fabriqué par / Fabricado por:

SHALINA LABORATORIES PVT. LTD.

96, Maker Chambers VI, Nariman Point, Mumbai - India.

At/A/Em: Plot No. E-2 & E-3, M.I.D.C. Jejuri, Tal. Purandar, Dist. Pune, Maharashtra - India.

www.shalina.com

E-F-P 20600451-05 037

Post a Comment

AdBlock Detected!
We have detected that you are using adblocking plugin in your browser.
The revenue we earn by the advertisements is used to manage this website, we request you to whitelist our website in your adblocking plugin.